BioShaft Water Technology Inc
Change company Symbol lookup
Select an option...
BSHF BioShaft Water Technology Inc
BAC Bank of America Corp
GSPH Geospatial Corp
SLV iShares Silver Trust
STOR Store Capital Corp
GLU Gabelli Global Utility & Income Trust
XLB Materials Select Sector SPDR® Fund
XLF Financial Select Sector SPDR® Fund
XLE Energy Select Sector SPDR® Fund
HSBC-A HSBC Holdings PLC
Go

Industrials : Commercial Services & Supplies | Company profile

Bioshaft Water Technology, Inc. is engaged in treating both industrial waste-water, primarily from the food and beverage sector and domestic waste-water. The Company's product is a domestic waste water treatment plant system. As of April 30, 2016, it has over 30 domestic waste water plants in use around the world that use the BioShaft technology, which is made using BioShaft unit. BioShaft unit works by emulating and accelerating a natural process found in rivers. The waste water treatment plant system for which the Company uses its BioShaft unit is called the BioShaft System. Its BioShaft System consists of over four treatment phases with BioShaft unit used in the second treatment phase. The four treatment phases are Mechanical/Primary Treatment Phases (Pretreatment phase), Biological/Secondary Treatment Phase, Tertiary Treatment Phase and Sludge Treatment. Its turbo moving bed bio reactor (T-MBBR) BioShaft Packaged system is mobile and delivered ready for immediate installation.

Closing Price
$0.007
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.007
Day's Low
0.007
Volume
(Heavy Day)
Volume:
5,000

10-day average volume:
3,931
5,000

UPDATE: Caesars' stock soars toward biggest gain in 2 years after reports of merger interest

2:25 pm ET October 17, 2018 (MarketWatch)
Print

Shares of Caesars Entertainment Corp. (CZR) shot up 12% on heavy volume in afternoon trade Wednesday, after reports that Tilman Fertitta, the billionaire owner of the Golden Nugget Casinos and the NBA's Houston Rockets, is interested in a merger deal. Volume ballooned to 64.2 million shares, compared with the full-day average of about 13.8 million shares. The rally puts the stock on track for the biggest one-day gain since September 2016. Reuters reported (https://www.reuters.com/article/us-caesars-m-a-fertitta-exclusive/exclusive-casino-mogul-fertitta-approaches-caesars-about-merger-sources-idUSKCN1MR27Z) that Fertitta approached Caesars about reverse merger deal in which Caesars would be the acquirer. CNBC reported (https://www.cnbc.com/2018/10/17/tilman-fertitta-and-advisors-offered-13-a-share-in-cash-and-stock-for-caesars---sources.html?&qsearchterm=caesars) that Fertitta wants to make a deal with Caesars that values the casino at $13 a share, or 43% above Tuesday's closing price of $9.09. Caesars declined to comment. The stock, which closed at a 20-month low on Monday, has still lost 12% over the past three months, while the S&P 500 has slipped 0.3%.

-Tomi Kilgore; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

October 17, 2018 14:25 ET (18:25 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.